Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07130214) titled 'The Effect of Genetic Polymorphisms on the Success of Vital Pulp Therapy' on Aug. 12.
Study Type: Observational [Patient Registry]
Primary Sponsor: Ataturk University
Condition:
Pulp Exposure, Dental
Pulp Disease, Dental
Pulp Caping
Pulpitis
Pulpitis - Irreversible
Pulpal Inflammation
Intervention:
Drug: Biodentine
Recruitment Status: Not recruiting
Date of First Enrollment: May 2, 2025
Target Sample Size: 96
Countries of Recruitment:
Turkey
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07130214
Published by HT Digital Content Services with permission from Health Daily Digest....